A Phase 2a, Randomized, Double-Blind, Multicenter,
Placebo-Controlled Study to Assess the Safety, Tolerability,
Pharmacokinetics, and Efficacy of EYP001a in Patients With
Nonalcoholic Steatohepatitis
Please contact us for more information or to learn if you are eligible to participate.
